Please assess the completion status of the following clinical trial:

Trial Title: Study Comparing Olanzapine With Haloperidol for the Relief of Nausea and Vomiting in Patients With Advanced Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* \>18 years of age~* Significant nausea/vomiting~* Failed maxeran and domperidone~* Underlying treatment of causes has failed~* Adequate cognitive function~* Communicates well~Exclusion Criteria:~* Partial/complete bowel obstruction~* Currently taking Haldol or olanzapine~* Has drug induced extrapyramidal symptoms~* Parkinson's disease~* Undergoing chemotherapy or radiotherapy (RT) to brain, abdomen, stomach or esophagus

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).